Beckman Coulter Exhibits New Lab Solutions in Dubai

By LabMedica International staff writers
Posted on 08 Feb 2017
Beckman Coulter, Inc., an international leader in developing clinical diagnostic products and solutions, exhibited its laboratory solutions, including its DxN VERIS molecular diagnostics system and DxH 500 hematology system, at MEDLAB 2017.

The company’s DxN VERIS molecular diagnostics system aims to revolutionize laboratory workflow by delivering greater productivity and increased flexibility to laboratories, ensuring that results are available to physicians as quickly as possible, for faster clinical decision-making and positively impacting the patient pathway.

Image: The DxN molecular diagnostics system (Photo courtesy of Beckman Coulter).

Beckman Coulter’s DxH 500 hematology system is the first of a new series of advanced hematology analyzers specifically designed for laboratories with low-volume hematology workloads. With its small sample volume requirements, intuitive software and low reagent consumption, the advanced 5-part differential system aims to simplify the workload in a low-volume lab.

Also on display at the 4-day event held from February 6-9, 2017, in Dubai, UAE, was Beckman Coulter’s DxH Connected Workcells solution for in vitro diagnostic use. In addition to reducing manual work with accurate first-pass results and processing specimens faster with customizable workflow solutions for labs, it delivers reliable results from difficult specimens and also simplifies autovalidation with comprehensive data management.


Latest MEDLAB 2017 News